Axiom Investment Management LLC

Position in ABBV — AbbVie Inc.

CIK 1513703 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,209,381

+$188,267 QoQ

Shares Held

4,806

+2.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

#2,372

of 4,152 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Axiom Investment Management LLC holds $9,628,805 across 10 Drug Manufacturers - General names. ABBV ranks #4 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	86,053	$2,072,142
2	LLY	ELI LILLY & Co	1,400	$1,679,191
3	BMY	Bristol Myers Squibb Co	23,292	$1,342,081
4	ABBV	AbbVie Inc. This page	4,806	$1,209,381
5	JNJ	Johnson & Johnson	3,978	$1,010,288
6	MRK	Merck & Co., Inc.	6,417	$824,580
7	GILD	Gilead Sciences, Inc.	6,343	$801,374
8	NVS	Novartis AG	3,326	$521,249

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,209,381	4,806	+2.4%	Shares	Sole	2026-07-31
2026-03-31	$1,021,114	4,695	-44.0%	Shares	Sole	2026-05-26
2022-12-31	$1,355,261	8,386	+13.9%	Shares	Sole	2023-02-14
2022-09-30	$988,187	7,363	+0.3%	Shares	Sole	2022-11-14
2022-06-30	$1,124,194	7,340	+0.3%	Shares	Sole	2022-08-15
2022-03-31	$1,186,482	7,319	-5.3%	Shares	Sole	2022-05-13
2021-12-31	$1,046,506	7,729	-8.6%	Shares	Sole	2022-02-02
2021-09-30	$911,930	8,454	+0.3%	Shares	Sole	2021-10-18
2021-06-30	$949,329	8,428	-34.7%	Shares	Sole	2021-08-16
2021-03-31	$1,396,362	12,903	+2311.8%	Shares	Sole	2021-05-20
2020-12-31	$57,325	535	-94.4%	Shares	Sole	2021-02-11
2020-09-30	$840,861	9,600	-3.2%	Shares	Sole	2021-03-16
2020-06-30	$973,649	9,917	+114.1%	Shares	Sole	2021-03-16
2020-03-31	$352,835	4,631	—	Shares	Sole	2021-03-16
No filing history on record for this holder in this stock.